Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Wopereis, Suzan ^b   Wolvers, Danielle ^a   Van Erk, Marjan ^b   Gribnau, Michiel ^a   Kremer, Bas ^b   Van Dorsten, Ferdi A ^a,c   Boelsma, Esther ^b   Garczarek, Ursula ^a   Cnubben, Nicole ^b   Frenken, Leon ^a   Van Der Logt, Paul ^a   Hendriks, Henk Fj ^b   Albers, Ruud ^a,d,e   Van Duynhoven, John ^a,c,e   Van Ommen, Ben ^b   Jacobs, Doris M ^a,c  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b TNO   (Netherlands)

^c Netherlands Metabolomics Center   (Netherlands)

^d NutriLeads Innovations   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Challenge test; Glucose; Inflammation; Lipid; OGTT; OLTT; Oxylipins; Resilience

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; OXYLIPIN; PADGEM PROTEIN; SERUM AMYLOID A; THROMBOMODULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; WATER;

ADULT; ARTICLE; BLOOD CELL; BLOOD SAMPLING; DISEASE RESISTANCE; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INFLAMMATION RESISTANCE; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; LIQUID CHROMATOGRAPHY; LYMPHOCYTE COUNT; MALE; METABOLIC REGULATION; NEUTROPHIL COUNT; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROVOCATION TEST; TANDEM MASS SPECTROMETRY; TEST MEAL; VOLUNTEER;

BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; FEMALE; GLUCOSE; HEALTHY VOLUNTEERS; HOMEOSTASIS; HUMANS; INFLAMMATION; KINETICS; MALE; MIDDLE AGED; OXYLIPINS; TRANSCRIPTOME;

EID: 84886221897     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-44     Document Type: Article

References (52)

1. WHO, Constitution of the world health organization 2006 http://www.who.int/governance/eb/who-constitution-en.pdf
2. How should we define health? Huber M, Knottnerus JA, Green L, der HH v, Jadad AR, Kromhout D, et al. BMJ 2011 343 4163 10.1136/bmj.d4163 21791490
3. The dynamic range of the human metabolome revealed by challenges. Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M, et al. FASEB J 2012 26 2607 2619 10.1096/fj.11-198093 22426117
4. Challenging homeostasis to define biomarkers for nutrition related health. van OB, Keijer J, Heil SG, Kaput J, Mol Nutr Food Res 2009 53 795 804 10.1002/mnfr.200800390 19517455
5. Nutrient sensing and inflammation in metabolic diseases. Hotamisligil GS, Erbay E, Nat Rev Immunol 2008 8 923 934 10.1038/nri2449 19029988
6. Fatty acids and postprandial inflammation. Margioris AN, Curr Opin Clin Nutr Metab Care 2009 12 129 137 10.1097/MCO.0b013e3283232a11 19202384
7. Postprandial variations of plasma inflammatory markers in abdominally obese men. Blackburn P, Despres JP, Lamarche B, Tremblay A, Bergeron J, Lemieux I, et al. Obesity (Silver Spring) 2006 14 1747 1754 10.1038/oby.2006.201 17062804 (Pubitemid 46214797)
8. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da RR, Maier A, et al. Diabetes 2004 53 701 710 10.2337/diabetes.53.3.701 14988255 (Pubitemid 38270640)
9. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Ceriello A, Assaloni R, Da RR, Maier A, Piconi L, Quagliaro L, et al. Circulation 2005 111 2518 2524 10.1161/01.CIR.0000165070. 46111.9F 15867169 (Pubitemid 40696141)
10. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, Mohanty P, et al. Diabetes Care 2010 33 991 997 10.2337/dc09-1630 20067961
11. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Circulation 2002 106 2067 2072 10.1161/01.CIR.0000034509.14906.AE 12379575 (Pubitemid 35192812)
12. Postprandial leukocyte increase in healthy subjects. van Oostrom AJ, Sijmonsma TP, Rabelink TJ, Van Asbeck BS, Cabezas MC, Metabolism 2003 52 199 202 10.1053/meta.2003.50037 12601632 (Pubitemid 36388843)
13. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. van Oostrom AJ, van Wijk JP, Sijmonsma TP, Rabelink TJ, Castro Cabezas M, Neth J Med 2004 62 320 325 15635816 (Pubitemid 39406483)
14. Activation of leukocytes by postprandial lipemia in healthy volunteers. van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP, et al. Atherosclerosis 2004 177 175 182 10.1016/j.atherosclerosis.2004.07. 004 15488881 (Pubitemid 39361153)
15. Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Derosa G, Ferrari I, D'Angelo A, Salvadeo SA, Fogari E, Gravina A, et al. Heart Vessels 2009 24 204 210 10.1007/s00380-008-1109-y 19466522
16. Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects. Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Gravina A, et al. Microvasc Res 2010 79 144 149 10.1016/j.mvr.2010.01.002 20079360
17. Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load. Poppitt SD, Keogh GF, Lithander FE, Wang Y, Mulvey TB, Chan YK, et al. Nutrition 2008 24 322 329 10.1016/j.nut.2007.12.012 18262390
18. Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Tulk HM, Robinson LE, Metabolism 2009 58 1709 1716 10.1016/j.metabol.2009.05.031 19625064
19. Sample size of 12 per group rule of thumb for a pilot study. Julious SA, Pharm Stat 2005 4 287 291 10.1002/pst.185 (Pubitemid 43013602)
20. The latin square design in clinical experimentation. Chilton NW, J Dent Res 1955 34 421 428 10.1177/00220345550340031801 14381580
21. Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Balvers MGJ, Verhoeckx KCM, Bijlsma S, Rubingh CM, Meijerink J, Wortelboer HM, et al. Metabolomics 2012 8 1130 1147 10.1007/s11306-012-0421-9 23136559
22. A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Lundman P, Boquist S, Samnegard A, Bennermo M, Held C, Ericsson CG, et al. Nutr Metab Cardiovasc Dis 2007 17 195 202 10.1016/j.numecd.2005.11. 009 17367705 (Pubitemid 46400410)
23. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, et al. J Am Coll Cardiol 2002 39 1145 1150 10.1016/S0735-1097(02)01741-2 11923038 (Pubitemid 34267417)
24. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NH, et al. Am J Clin Nutr 2010 91 1044 1059 10.3945/ajcn.2009.28822 20181810
25. Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. van Erk MJ, Wopereis S, Rubingh C, Van VT, Verheij E, Cnubben NH, et al. BMC Med Genomics 2010 3 5 10.1186/1755-8794-3-5 20178593
26. Genetic effects on postprandial variations of inflammatory markers in healthy individuals. Cheng YC, Kao WH, Mitchell BD, Sharrett AR, Ryan KA, Vogel RA, et al. Obesity (Silver Spring) 2010 18 1417 1422 10.1038/oby.2009.416 19910936
27. Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys. MacEneaney OJ, Harrison M, O'Gorman DJ, Pankratieva EV, O'Connor PL, Moyna NM, Eur J Appl Physiol 2009 106 721 729 10.1007/s00421-009- 1073-y 19430945
28. Postprandial cell inflammatory response to a standardised fatty meal in subjects at different degree of cardiovascular risk. Tamburrelli C, Gianfagna F, D'Imperio M, De CA, Rotilio D, Iacoviello L, et al. Thromb Haemost 2012 107 530 537 10.1160/TH11-09-0674 22274593
29. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, et al. J Lipid Res 2003 44 576 583 10.1194/jlr.M200419-JLR200 12562833 (Pubitemid 37279707)
30. Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients. Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Gravina A, et al. Horm Metab Res 2010 42 8 13 10.1055/s-0029-1237728 19735057
31. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Campbell CG, Brown BD, Dufner D, Thorland WG, Lipids 2006 41 257 265 10.1007/s11745-006-5095-5 16711600
32. Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial. van Dijk SJ, Mensink M, Esser D, Feskens EJ, Muller M, Afman LA, PLoS One 2012 7 41388 10.1371/journal.pone.0041388 22844471
33. Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes. Madec S, Corretti V, Santini E, Ferrannini E, Solini A, Br J Nutr 2011 106 364 368 10.1017/S0007114511000286 21385511
34. Impact of circulating esterified eicosanoids and other oxylipins on endothelial function. Shearer GC, Newman JW, Curr Atheroscler Rep 2009 11 403 410 10.1007/s11883-009-0061-3 19852880
35. Effects of dynamic exercise on plasma arachidonic acid epoxides and diols in human volunteers. Giordano RM, Newman JW, Pedersen TL, Ramos MI, Stebbins CL, Int J Sport Nutr Exerc Metab 2011 21 471 479 22089302
36. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC, J Lipid Res 2009 50 204 213 18812596
37. Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE. Buchanan MR, Horsewood P, Brister SJ, Prostaglandins Leukot Essent Fatty Acids 1998 58 339 346 10.1016/S0952-3278(98)90069-2 9690711 (Pubitemid 28329081)
38. Suppression of proto-oncogene (AP-1) in a model of skin epidermal hyperproliferation is reversed by topical application of 13- hydroxyoctadecadienoic acid and 15-hydroxyeicosatrienoic acid. Xi S, Pham H, Ziboh VA, Prostaglandins Leukot Essent Fatty Acids 2000 62 13 19 10.1054/plef.1999.0119 10765974 (Pubitemid 30184572)
39. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. Lefebvre P, Chinetti G, Fruchart JC, Staels B, J Clin Invest 2006 116 571 580 10.1172/JCI27989 16511589 (Pubitemid 43326861)
40. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Chinetti G, Fruchart JC, Staels B, Inflamm Res 2000 49 497 505 10.1007/s000110050622 11089900
41. Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. Shearer GC, Harris WS, Pedersen TL, Newman JW, J Lipid Res 2010 51 2074 2081 10.1194/M900193-JLR200 19671931
42. Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Konkel A, Schunck WH, Biochim Biophys Acta 2011 1814 210 222 10.1016/j.bbapap.2010.09.009 20869469
43. Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. Dekker MJ, Wright AJ, Mazurak VC, Marangoni AG, Rush JW, Graham TE, et al. J Nutr Biochem 2009 20 694 704 10.1016/j.jnutbio.2008.06.012 18829281
44. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Jellema A, Plat J, Mensink RP, Eur J Clin Invest 2004 34 766 773 10.1111/j.1365-2362.2004.01414.x 15530150 (Pubitemid 39524302)
45. Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. Dixon NC, Hurst TL, Talbot DC, Tyrrell RM, Thompson D, J Appl Physiol 2009 107 63 68 10.1152/japplphysiol.91532.2008 19423836
46. Serum concentrations of interleukin-6 are increased when sampled through an indwelling venous catheter. Gudmundsson A, Ershler WB, Goodman B, Lent SJ, Barczi S, Carnes M, Clin Chem 1997 43 2199 2201 9365415 (Pubitemid 27497829)
47. Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction. Kempf K, Haltern G, Futh R, Herder C, Muller-Scholze S, Gulker H, et al. Horm Metab Res 2006 38 346 351 10.1055/s-2006-925403 16718633 (Pubitemid 43864958)
48. Postprandial cytokine concentrations and meal composition in obese and lean women. Manning PJ, Sutherland WH, McGrath MM, de Jong SA, Walker RJ, Williams MJ, Obesity (Silver Spring) 2008 16 2046 2052 10.1038/oby.2008.334 19186329
49. Postprandial endothelial function, inflammation, and oxidative stress in obese children and adolescents. Metzig AM, Schwarzenberg SJ, Fox CK, Deering MM, Nathan BM, Kelly AS, Obesity (Silver Spring) 2011 19 1279 1283 10.1038/oby.2010.318 21233813
50. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. J Clin Endocrinol Metab 1997 82 4196 4200 10.1210/jc.82.12.4196 9398739 (Pubitemid 27525539)
51. Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Fuerstenberg RK, Weatherbee JA, et al. In Vivo 1995 9 331 339 8555432
52. Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Taudorf S, Krabbe KS, Berg RM, Pedersen BK, Moller K, Clin Vaccine Immunol 2007 14 250 255 10.1128/CVI.00380-06 17267590 (Pubitemid 46570280)